Comment[ArrayExpressAccession] E-GEOD-55319 MAGE-TAB Version 1.1 Public Release Date 2014-02-26 Investigation Title Whole Blood Gene Expression Profiling Predicts Therapeutic Response in Polyarticular Juvenile Idiopathic Arthritis at 4 Months Comment[Submitted Name] Whole Blood Gene Expression Profiling Predicts Therapeutic Response in Polyarticular Juvenile Idiopathic Arthritis at 4 Months Experiment Description To determine whether gene expression profiles from peripheral whole blood could be used to determine therapeutic outcome in a cohort of children with newly diagnosed polyarticular JIA. 19 samples were obtained from healthy childhood controls and 93 samples from patients with juvenile idiopathic arthritis. For patient samples, they were collected prior to treatment (month 0) or 4 months after treatment. Term Source Name ArrayExpress EFO Term Source File http://www.ebi.ac.uk/arrayexpress/ http://www.ebi.ac.uk/efo/efo.owl Person Last Name Frank Jiang Sawle Frank Chen Wallace Jarvis Person First Name Bart Kaiyu Ashley Mark Yanmin Carol James Person Mid Initials D B A N Person Email frank@omrf.org Person Affiliation OMRF Person Address OMRF, 825 NE 13 St, Oklahoma City, OK, USA Person Roles submitter Protocol Name P-GSE55319-1 P-GSE55319-4 P-GSE55319-5 P-GSE55319-2 P-GSE55319-3 P-GSE55319-6 Protocol Description Because of microarray product changes in the course of the study, raw data were reduced to contain 39426 common probes between the microarrays. Data in Matrix (raw) table contain values from Illumina's Genome Studio software and detection p-values above background. Sample tables contain variance stabilized and robust spline values from the lumi package. Batch effects were removed using the ComBat algorithm in the sva package. ID_REF = VALUE = normalized data cRNA was produced from reverse transcribed cDNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Inc., Austin). cRNA was hybridized to Illumina WG-6 v3 or Illumina HT-12 v4 human whole genome microarrays, and stained according to the manufacturer’s directions. 2.5 ml of blood was collected in a PAXgene tube (PreAnalytiX GmbH, Hilden, Germany). Samples were stored at -80 C prior to RNA extraction. RNA was purified from whole blood PAXgene specimens using a PAXgene Blood RNA kit (Qiagen,Valencia, CA) as recommended by the manufacturer, including a DNAse (Qiagen) step to remove genomic DNA. Globin transcripts were reduced using GLOBINclear-Human (Ambion , Austin, TX ). Scanning was performed using Illumina's iScan scanner Protocol Type normalization data transformation protocol labelling protocol hybridization protocol sample treatment protocol nucleic acid extraction protocol array scanning protocol Experimental Factor Name PATIENT ID GROUP MONTH OF VISIT SEX Experimental Factor Type patient id group month of visit Sex Comment[SecondaryAccession] GSE55319 Comment[GEOReleaseDate] 2014-02-26 Comment[ArrayExpressSubmissionDate] 2014-02-25 Comment[GEOLastUpdateDate] 2014-02-26 Comment[AEExperimentType] transcription profiling by array Comment[AdditionalFile:Data1] GSE55319.txt Comment[AdditionalFile:Data2] GSE55319_non-normalized.txt SDRF File E-GEOD-55319.sdrf.txt